Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Kiniksa Pharmaceuticals International, plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +8 vs. Q2 2023
- Shares held
- 34.9M
- +4.60M (+15.2%) vs. Q2 2023
- Total value
- $605.8M
- +$179.5M (+42.1%) vs. Q2 2023
- New holders
- 19
- 49 more added
- Sold out
- 11
- 43 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $2.99B |
| Q1 2026 | 228 | $2.18B |
| Q4 2025 | 224 | $1.77B |
| Q3 2025 | 204 | $1.59B |
| Q2 2025 | 189 | $1.10B |
| Q1 2025 | 176 | $889.4M |
| Q4 2024 | 160 | $773.1M |
| Q3 2024 | 176 | $991.2M |
| Q2 2024 | 133 | $659.4M |
| Q1 2024 | 154 | $768.1M |
| Q4 2023 | 142 | $600.4M |
| Q3 2023 | 134 | $605.8M |
| Q2 2023 | 127 | $447.7M |
| Q1 2023 | 132 | $339.6M |
| Q4 2022 | 125 | $450.0M |
| Q3 2022 | 104 | $383.2M |
| Q2 2022 | 92 | $290.5M |
| Q1 2022 | 96 | $306.0M |
| Q4 2021 | 103 | $346.4M |
| Q3 2021 | 101 | $332.0M |
| Q2 2021 | 102 | $402.0M |
| Q1 2021 | 105 | $537.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisory Research Inc | 204,098 | $3.55M | 0.49% | +173,546+568.0% | Added |
| Charles Schwab Investment Management Inc | 206,983 | $3.60M | 0.00% | −12,104−5.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 208,500 | $3.62M | 0.03% | +134,070+180.1% | Added |
| Susquehanna International Group, LLP | 209,420 | $3.64M | 0.01% | +195,772+1,434.4% | Added |
| Invesco Ltd. | 212,596 | $3.69M | 0.00% | +212,596 | New |
| Acadian Asset Management LLC | 226,181 | $3.92M | 0.02% | +203,933+916.6% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 242,500 | $4.21M | 0.02% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 256,932 | $4.46M | 0.02% | +96,288+59.9% | Added |
| Northern Trust Corp | 296,119 | $5.14M | 0.00% | +7,842+2.7% | Added |
| Hudson Bay Capital Management LP | 302,500 | $5.25M | 0.05% | −377,500−55.5% | Reduced |
| D. E. Shaw & Co., Inc. | 317,519 | $5.52M | 0.01% | +78,919+33.1% | Added |
| AQR Capital Management LLC | 323,578 | $5.62M | 0.01% | −187,444−36.7% | Reduced |
| Ameriprise Financial Inc | 346,867 | $6.03M | 0.00% | −24,408−6.6% | Reduced |
| Dimensional Fund Advisors LP | 373,721 | $6.49M | 0.00% | −1,388−0.4% | Reduced |
| GMT Capital Corp | 477,853 | $8.30M | 0.31% | +178,609+59.7% | Added |
| Driehaus Capital Management LLC | 503,750 | $8.75M | 0.11% | +503,750 | New |
| Parkman Healthcare Partners LLC | 509,810 | $8.86M | 1.62% | +218,107+74.8% | Added |
| Granahan Investment Management Inc | 534,214 | $9.28M | 0.33% | −2,215−0.4% | Reduced |
| Nuveen Asset Management, LLC | 563,926 | $9.80M | 0.00% | +450,181+395.8% | Added |
| Tang Capital Management LLC | 600,000 | $10.4M | 1.47% | 00.0% | Unchanged |
| Millennium Management LLC | 605,574 | $10.5M | 0.01% | +272,828+82.0% | Added |
| Rice Hall James & Associates, LLC | 650,366 | $11.3M | 0.72% | −9,758−1.5% | Reduced |
| Geode Capital Management, LLC | 659,569 | $11.5M | 0.00% | +46,917+7.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 698,741 | $12.1M | 0.27% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 760,353 | $13.2M | 0.16% | −224,843−22.8% | Reduced |
| Goldman Sachs Group Inc | 865,782 | $15.0M | 0.00% | +494,264+133.0% | Added |
| Morgan Stanley | 1,491,489 | $25.9M | 0.00% | +182,746+14.0% | Added |
| Pictet Asset Management Holding SA | 1,604,717 | $27.9M | 0.03% | +1,604,717 | New |
| State Street Corp | 1,761,672 | $30.6M | 0.00% | +109,701+6.6% | Added |
| Fairmount Funds Management LLC | 2,474,561 | $43.0M | 5.17% | +1,770,102+251.3% | Added |
| Baker Bros. Advisors LP | 2,809,577 | $48.8M | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,958,957 | $51.4M | 0.00% | −128,255−4.2% | Reduced |
| Rubric Capital Management LP | 3,077,449 | $53.5M | 2.25% | −300,715−8.9% | Reduced |
| BlackRock Inc. | 3,118,308 | $54.2M | 0.00% | −42,116−1.3% | Reduced |
| Woodline Partners LP | 0 | $0 | 0.00% | −290,001−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −84,447−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −40,439−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −40,294−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −25,669−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −19,081−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −17,349−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −11,025−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −10,474−100.0% | Sold out |
| 25 LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |